Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
14 November 2018Website:
http://www.vapotherm.comNext earnings report:
02 August 2024Last dividends:
N/ANext dividends:
N/APrice
regular market | Wed, 03 Jul 2024 13:30:00 GMTDividend
Analysts recommendations
Institutional Ownership
VAPO Latest News
LOS ANGELES, CA / ACCESSWIRE / July 1, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Vapotherm, Inc. ("Vapotherm" or "the Company") (OTCQX:VAPO) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the Vapotherm board breached its fiduciary duties to shareholders.
LOS ANGELES, CA / ACCESSWIRE / June 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Vapotherm, Inc. ("Vapotherm" or "the Company") (OTCQX:VAPO) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the Vapotherm board breached its fiduciary duties to shareholders.
LOS ANGELES, CA / ACCESSWIRE / June 29, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Vapotherm, Inc. ("Vapotherm" or "the Company") (OTCQX:VAPO) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the Vapotherm board breached its fiduciary duties to shareholders.
LOS ANGELES, CA / ACCESSWIRE / June 28, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Vapotherm, Inc. ("Vapotherm" or "the Company") (OTCQX:VAPO) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the Vapotherm board breached its fiduciary duties to shareholders.
LOS ANGELES, CA / ACCESSWIRE / June 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Vapotherm, Inc. ("Vapotherm" or "the Company") (OTCQX:VAPO) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the Vapotherm board breached its fiduciary duties to shareholders.
LOS ANGELES, CA / ACCESSWIRE / June 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Vapotherm, Inc. ("Vapotherm" or "the Company") (OTCQX:VAPO) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the Vapotherm board breached its fiduciary duties to shareholders.
LOS ANGELES, CA / ACCESSWIRE / June 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Vapotherm, Inc. ("Vapotherm" or "the Company") (OTCQX:VAPO) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the Vapotherm board breached its fiduciary duties to shareholders.
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Vapotherm, Inc. ("Vapotherm" or "the Company") (OTC:VAPO) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the Vapotherm board breached its fiduciary duties to shareholders.
LOS ANGELES, CA / ACCESSWIRE / June 22, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Vapotherm, Inc. ("Vapotherm" or "the Company") (OTC:VAPO) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the Vapotherm board breached its fiduciary duties to shareholders.
LOS ANGELES, CA / ACCESSWIRE / June 21, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Vapotherm, Inc. ("Vapotherm" or "the Company") (OTC:VAPO) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the Vapotherm board breached its fiduciary duties to shareholders.
- 1(current)
What type of business is Vapotherm?
Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor, which provides compressed air necessary to run the precision flow systems; aerosol aeroneb adaptor to facilitate delivery of ultrasonic aerosolized medication; aerosol disposable patient circuit that is designed to streamline the provision of continuous and intermittent delivery of aerosol medication; and tracheostomy adaptors. In addition, Vapotherm, Inc. offers ProSoft cannula to provide gentle contact with the skin; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Modules, which helps clinicians maintain oxygen levels within a target range. The company sells its products to hospitals. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.
What sector is Vapotherm in?
Vapotherm is in the Healthcare sector
What industry is Vapotherm in?
Vapotherm is in the Medical Devices industry
What country is Vapotherm from?
Vapotherm is headquartered in United States
When did Vapotherm go public?
Vapotherm initial public offering (IPO) was on 14 November 2018
What is Vapotherm website?
https://www.vapotherm.com
Is Vapotherm in the S&P 500?
No, Vapotherm is not included in the S&P 500 index
Is Vapotherm in the NASDAQ 100?
No, Vapotherm is not included in the NASDAQ 100 index
Is Vapotherm in the Dow Jones?
No, Vapotherm is not included in the Dow Jones index
When does Vapotherm report earnings?
The next expected earnings date for Vapotherm is 02 August 2024